Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder

Comprehensive Psychiatry

Volumn 39, Issue 6, 1998, Pages 323-332

  Grilo, Carlos M ^b   Money, Roy ^b   Barlow, David H ^b   Goddard, Andrew W ^b   Gorman, Jack M ^b   Hofmann, Stefan G ^b   Papp, Laszlo A ^b   Shear, M Katherine ^b   Woods, Scott W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; COPING BEHAVIOR; CORRELATION FUNCTION; DEMOGRAPHY; DISEASE SEVERITY; EDUCATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; PANIC; PERSONALITY; STATISTICAL ANALYSIS;

EID: 0031725131     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(98)90043-8     Document Type: Article

References (54)

1. Baekelan F, Lundwall L. Dropping out of treatment: A critical review. Psychol Bull 1975;82:738-783.
2. Hillis G, Alexander DA, Egales JM. Premature termination of psychiatric contact. Int J Soc Psychiatry 1993;39:100-107.
3. Blood L, Cornwall A. Pretreatment variables that predict completion of an adolescent substance abuse treatment program. J Nerv Ment Dis 1994;182:14-19.
4. Gottheil E, Sterling RC, Weinstein SP. Pretreatment dropouts: Characteristics and outcomes. J Addict Dis 1997;16:1-14.
5. Piper WE, Joyce AS, Azim HF, Rosie JS. Patient characteristics and success in day treatment. J Nerv Ment Dis 1994;182: 381-386.
6. Rabin AS, Kaslow NJ, Rehm LP. Factors influencing continuation in behavioral therapy. Behav Res Ther 1985;23:695-698.
7. Ryan RM, Plant RW, O'Malley S. Initial motivations for alcohol treatment: relations with patient characteristics, treatment involvement, and dropout. Addict Behav 1995;20:279-297.
8. Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, et al. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord 1994;30: 273-281.
9. Luborsky L. Factors influencing the outcome of psychotherapy: A review of quantitative research. Psychol Bull 1971;75: 145-185.
10. Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK, et al. Pretreatment attrition in a comparative treatment outcome study on panic disorder. Am J Psychiatry 1998;155:43-47.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1987.
12. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford, 1988.
13. DiNardo PA, Moras K, Barlow DH, Rapee RM, Brown TA. Reliability of DSM-III-R anxiety-disorder categories using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry 1993;50:251-256.
14. Barlow DH, Craske M. Mastering Your Anxiety and Panic II. New York, NY: Graywind, 1994.
15. Barlow DH, Craske MG, Cerny JA, Klosko JS. Behavioral treatment of panic disorder. Behav Res Ther 1989;20:261-282.
16. Basoglu M, Marks IM, Swinson RP, Noshirvani H, O'Sullivan G, Kuch K. Pretreatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. J Affect Disord 1994;30:123-132.
17. de Beurs E, Lange A, van Dyck R, Koele P. Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome. Aust NZ J Psychiatry 1995;29:104-113.
18. Faravelli C, Paterniti S, Scarpato A. 5-year prospective, naturalistic follow-up study of panic disorder. Compr Psychiatry 1995;36:271-277.
19. Katschnig H, Amering M, Stolk JM, Ballenger JC. Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial. Psychopharmacol Bull 1996;32:149-155.
20. Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzer-Brody S, Rosenbaum JF. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol 1993;13:257-263.
21. Black DW, Wesner RB, Gabel J, Bowers W, Monahan P. Predictors of short-term treatment response in 66 patients with panic disorder. J Affect Disord 1994;30:233-241.
22. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995;63:754-765.
23. Scheibe G, Albus M. Predictors of outcome in panic disorder: a 5-year prospective follow-up study. J Affect Disord 1996;41:111-116.
24. Woodman CL, Noyes R, Jr., Ballenger JC, Lydiard RB, Sievers G, Mihalko D. Predictors of response to alprazolam and placebo in patients with panic disorder. J Affect Disord 1994;30: 5-13.
25. Katschnig H, Amering M, Stolk JM, Klerman GL, Ballenger JC, Briggs A, et al. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 1995;167:487-494.
26. Noyes R, Jr., Reich J, Christiansen J, Suelzer M, Pfohl B, Coryell WA. Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 1990;47:809-818.
27. Slaap BR, van Vliet IM, Westenberg HG, den Boer JA. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report). J Affect Disord 1995;33:31-38.
28. Riskand JH, Beck AT, Brown GB, Steer RA. Taking the measure of anxiety and depression: Validity of reconstructed Hamilton Scales. J Nerv Men Dis 1987;175:474-479.
29. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
30. Guy W. ECDEU assessment manual for psychopharmacology. US DHEW pub. No. 76-338. Washington, DC: US Government Printing Office, 1976.
31. Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behav Res Ther 1986;24:1-8.
32. Maller RG, Reiss S. A behavioral validation of the Anxiety Sensitivity Index. J Anxiety Disord 1987;1:265-272.
33. Taylor S. Anxiety sensitivity: Theoretical perspectives and recent findings. Behav Res Ther 1995;33:243-258.
34. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
35. Borkovec TD, Mathews AM. Treatment of nonphobic anxiety disorders: A comparison of nondirective, cognitive, and coping desensitization therapy. J Consult Clin Psychol 1988;56: 877-884.
36. Gershefski JJ, Arnkoff DB, Glass CR, Elkin I. Clients' perceptions of treatment for depression: I. Helpful aspects. Psychother Res 1996;6:233-247.
37. Meadows EA, Antony MM, Lilienfeld S, Barlow DH. Etiological attributions in panic disorder patients (poster). Annual Meeting of the Association for the Advancement of Behavior Therapy, Boston, MA, November 19-22, 1992.
38. Hansen AMD, Hoogduin CAL, Schaap C, de Haan E. Do drop-outs differ from successfully treated obsessive-compulsives? Res Ther 1992;30:547-550.
39. Aldwin C, Folkman S, Shaefer C, Coyne J, Lazarus R. Ways of coping checklist: A process measure. American Psychological Association Meeting. Montreal, Canada, August 1980.
40. Lazarus RS, Folkman S. Stress, appraisal, and coping. New York, NY: Springer, 1984.
41. Vitaliano PO, Russo J, Carr JE, Maiuro RD, Becker J. The ways of coping checklist: Revision and psychometric properties. Multivar Behav Res 1985;20:3-26.
42. Dreessen L, Arntz A, Luttels C, Sallaerts S. Personality disorders do not influence the results of cognitive behavior therapies for anxiety disorders. Compr Psychiatry 1994;35:265-274.
43. Hoffart A, Martinsen EW. The effect of personality disorders and anxious-depressive comorbidity on outcome in patients with unipolar depression and with panic disorder and agoraphobia. J Personal Disord 1993;7:304-311.
44. Klein MH, Benjamin LS, Rosenfeld R, Treece C, Husted J, Greist JH. The Wisconsin Personality Disorders Inventory: Development, reliability, and validity. J Personal Disord 1993;7: 285-303.
45. Fleiss JL, Williams JB, Dubro AF. The logistic regression analysis of psychiatric data. J Psychiatr Res 1986;20:145-209.
46. Heine RW, Trosman H. Initial expectations of the doctor-patient interaction as a factor in continuance in psychotherapy. Psychiatry 1960;23:275-278.
47. Koran LM, Costello RM. Early termination from group psychotherapy. Int J Group Psychother 1973;23:346-359.
48. Overall B, Aronson H. Expectations of psychotherapy in patients of lower socioeconomic class. Am J Orthopsychiatry 1963;33:421-430.
49. Conoley CW, Padula MA, Payton DS, Daniels JA. Predictors of client implementation of counselor recommendation. Match with problem, difficulty level, and client strengths. J Counsel Psychol 1994;41:3-8.
50. Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives. Soc Sci Med 1996;43:903-917.
51. Barnhoorn F, Adriaanse H. In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India [published erratum appears in Soc Sci Med 1992 Jun;34(11):II]. Soc Sci Med 1992;34:291-306.
52. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas, Woods SW, et al. The Multicenter Collaborative Panic Disorder Severity Scale. Am J Psychiatry 1997;154:1571-1575.
53. Hlatky MA. Patient preferences and clinical guidelines [editorial; comment]. JAMA 1995;273:1219-1220.
54. Bell DC, Williams ML, Nelson R, Spence RT. An experimental test of retention in residential and outpatient programs. Am J Drug Alcohol Abuse 1994;20:331-340.